Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


A Road-to-Market Analysis for Non-Small Cell Lung Cancer Products: Tyrosine Kinase Inhibitors as a case study

  • In: Poster Presentation
  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • Poster code: P-D-005-Monday
  • By: DELGADO-CHARRO, M Begona (University of Bath, Pharmacy and Pharmacology, Bath, United Kingdom)
  • Co-author(s): M Begona Delgado-Charro: Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom
    Enrico Tognana: European Medicines Agency, EMA, London, United Kingdom
    Francesco Pignatti: European Medicines Agency, EMA, London, United Kingdom
    Corinne De Vries: European Medicines Agency, EMA, London, United Kingdom
  • Abstract:

    Backgrounds

    Pre- and post- submission factors influence the Road-to-Market for medicinal products.

    Aims

    This work analysed the Road-to-Market for 10 NSCLC-TKIs products for which an MAA had been submitted.

    Methods

    The choice was based on the clinical relevance and potential identification of the most significant factors in the Road-to-Market for

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses